Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DSCR1 upregulation enhances dural meningeal lymphatic drainage to attenuate amyloid pathology of Alzheimer’s disease

ABSTRACT: DSCR1 upregulation enhances dural meningeal lymphatic drainage to attenuate amyloid pathology of Alzheimer’s disease

PROVIDER: PRJNA747299 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

DSCR1 upregulation enhances dural meningeal lymphatic drainage to attenuate amyloid pathology of Alzheimer’s disease

Project description:Purpose: To further understand the beneficial effects of DSCR1 on the lymphatic system of 5XFAD mice, we investigated the transcriptional landscape of meningeal lymphatic endothelial cells (mLECs) by performing RNA sequencing.

2021-08-16 | GSE180275 | GEO

Project description:The meningeal lymphatic network—housed within the dural meninges surrounding the brain— is critical for cerebrospinal fluid (CSF) drainage. Through continuous brain interstitial fluid (ISF) mixing with CSF via the glymphatic system, this lymphatic network facilitates the removal of central nervous system (CNS) waste. During aging and in Alzheimer’s disease (AD), attenuated meningeal lymphatic drainage promotes the buildup of toxic misfolded proteins—including amyloid beta—in the CNS. Alleviating this age-related meningeal lymphatic dysfunction represents a promising therapeutic strategy to alleviate AD pathology. However, the mechanisms underlying this lymphatic decline remain elusive. Here we demonstrate that age-related alterations in meningeal immunity contribute to meningeal lymphatic impairment. Single-cell RNA-sequencing of dural lymphatic endothelial cells in aged mice demonstrated a response signature to the cytokine IFNγ, which was elevated in the aged dura due to meningeal T cell accumulation. Chronic elevation of IFNγ in the meninges of young mice via AAV-mediated overexpression altered lymphatic adherans junctions and impaired CSF drainage to deep cervical lymph nodes—comparable to the deficits observed in aged mice. Direct disruption of lymphatic junctions via CSF-delivered VE-Cadherin disrupting antibodies was sufficient to phenocopy impairments in CSF drainage. Therapeutically, IFNγ neutralization in aged mice alleviated age-related impairments in meningeal lymphatic function. These data suggest manipulation of meningeal immunity as a viable therapeutic target to normalize CSF drainage in aged mice and alleviate the pathology in AD mice associated with impaired waste removal.

2023-03-10 | GSE217312 | GEO

2023-03-10 | GSE217276 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function

Project description:Immunotherapy against amyloid beta is modulated by meningeal lymphatic function

| PRJNA595161 | ENA

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function VI

Project description:A growing body of evidence points to passive immunotherapy as a promising therapeutic strategy against AD. Herein, we show that meningeal lymphatic vasculature becomes dysfunctional in AD transgenic mice and that manipulating meningeal lymphatic drainage affects the outcome of anti-Aβ immunotherapy.

2021-03-11 | GSE160220 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function V

2021-03-11 | GSE160219 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function IV

2021-03-11 | GSE160216 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function III

2021-03-11 | GSE141915 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function II

2021-03-11 | GSE141872 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function I

2021-03-11 | GSE141849 | GEO